Neoadjuvant apalutamide (APA) plus leuprolide (LHRHa) with or without abiraterone (AA) in localized high-risk prostate cancer (LHRPC).
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Eleni Efstathiou, Myrto A Boukovala, Nicholas Spetsieris, Sijin Wen, Anh Hoang, Justin Alexander Weldon, Rebecca Tidwell, John W. Davis, Brian Francis Chapin, Paul Gettys Corn, Sumit Kumar Subudhi, Ana Aparicio, Curtis Alvin Pettaway, Louis L. Pisters, John N. Papadopoulos, Mehrad Adibi, Jennifer Wang, Amado J. Zurita, Christopher Logothetis, Patricia Troncoso
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3031482046